ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Neumora Therapeutics, Inc. (NMRA)

NASDAQ

$3.20

$-0.06

(-1.85%)

Neumora Therapeutics, Inc. (NMRA) Live Price Chart

Page last updated: 2026-02-14 00:45:00

Key Market Data

Market Cap	$534.69M
Open	$3.30
High	$21.00
Low	$0.61
Previous Close	$3.25
Price Change	$-0.06
Percentage Change	-1.85%
Volume	4M

Neumora Therapeutics, Inc. (NMRA) Stock Price Today

Neumora Therapeutics, Inc. (NMRA) is currently trading at $3.20 as of 2026-02-14 00:45:00, reflecting a -1.85% move ($-0.06) from the previous close.

In the short term, the stock has returned +5,841.58% over the past four weeks. Over the last 12 months, Neumora Therapeutics, Inc. has recorded a +83.91% price change, indicating a strong performance relative to the broader market.

Neumora Therapeutics, Inc. (NMRA) 7-Day Stock Price Changes

Over the past seven days, Neumora Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $2.11 to the latest recorded price of $3.20, reflecting an intraday change of -1.85%. Daily movements highlight shifts in trading volume (3,731,812), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, NMRA has delivered a +5,841.58% return over the past month and a +83.91% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Neumora Therapeutics, Inc. (NMRA)

You can buy and trade NMRA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for NMRA and Execute Your Trade

Open the trading page, enter NMRA in the search bar, select the amount of NMRA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Neumora Therapeutics, Inc. (NMRA)?

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Neumora Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	95
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.neumoratx.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Neumora Therapeutics, Inc.?

The latest trading price for Neumora Therapeutics, Inc. (Common Stock) is $ 3.20, compared with a previous closing price of $ 3.25. That means the stock has moved -1.85% so far today. Intraday price updates and recent trading activity for NMRA can be tracked on the live chart and quote section on this page.

2.Is Neumora Therapeutics, Inc. stock going up or down?

Looking at recent performances, NMRA has returned +5,841.58% over the past month, +98.76% over the last six months and +83.91% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Neumora Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does NMRA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Neumora Therapeutics, Inc. has traded between a low of $ 0.61 and a high of $ 3.47. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether NMRA is currently nearer the top or the bottom of its one-year trading band.

4.How is Neumora Therapeutics, Inc. classified by sector and industry?

Neumora Therapeutics, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Neumora Therapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing NMRA’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Neumora Therapeutics, Inc.’s performance.

5.Where is Neumora Therapeutics, Inc. listed and how large is it by market value?

Neumora Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 534.69M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Neumora Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does NMRA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1.39 summarises how much profit Neumora Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Neumora Therapeutics, Inc.'s financial performance over time?

To follow Neumora Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how NMRA is performing and how the market is responding.

8.When is Neumora Therapeutics, Inc. expected to report earnings?

Neumora Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for NMRA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Neumora Therapeutics, Inc.'s earnings reports?

Neumora Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether NMRA is meeting, beating or missing expectations.

10.How can I stay informed about Neumora Therapeutics, Inc.'s results and guidance?

You can stay up to date on Neumora Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for NMRA on this page helps you see how new information is being reflected in the stock.

11.Does Neumora Therapeutics, Inc. pay a regular cash dividend to its shareholders?

Neumora Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor NMRA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for NMRA?

Based on the latest earnings data, NMRA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Neumora Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Neumora Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Neumora Therapeutics, Inc.?

Neumora Therapeutics, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is NMRA valued in terms of P/E ratio and EPS?

Neumora Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1.39. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Neumora Therapeutics, Inc.'s earnings. Comparing NMRA's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Neumora Therapeutics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

CHR

Innovation Beverage Group Limited

IBG

Lumentum Holdings Inc.

LITE

Top Gainers

Browse today's leading gainers in the US stock market

Digital Brands Group, Inc.

DBGI

Founder Group Limited

FGL

JIADE LIMITED

JDZG

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

NMRA-to-USD Calculator

Amount

NMRA

USD

1 NMRA = 3.2 USD